Insights Center

Mintz advised Relation, an industry leader in deploying computation and experimentation to drug discovery, on an equity investment of $15 million from GSK in connection with two simultaneous strategic collaborations with GSK, a global biopharma company. The collaborations are aimed at advancing the development of novel therapeutics for fibrotic diseases and osteoarthritis – conditions which affect millions worldwide and which currently have few treatments addressing their root causes. 

Mintz advised Greater Asia Pacific, a Hong Kong holding company, in the sale of the controlling interest in Microtek Product Services Co. Ltd. to Centre Testing International Group Co., Ltd. (CTI), a publicly traded Chinese company in the lab tasting space.  

ESG Co-chair Jennifer Rubin spoke with The Washington Post about a recent Fifth Circuit opinion, which struck down a Nasdaq rule aiming to encourage diversity on corporate boards. Jen shares that companies can still decide whether they want to provide board diversity information and how the ruling highlights the vast influence of board members on businesses.